Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
84.34
-1.20 (-1.40%)
At close: Jun 6, 2025, 4:00 PM
83.00
-1.34 (-1.59%)
After-hours: Jun 6, 2025, 6:15 PM EDT

Verona Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
7,6873,8001,7092,133444405
Upgrade
Market Cap Growth
314.06%122.40%-19.89%380.79%9.47%435.09%
Upgrade
Enterprise Value
7,5293,5871,4721,907283205
Upgrade
Last Close Price
84.3446.4419.8826.136.727.00
Upgrade
PS Ratio
58.7789.89-4657.4011.09-
Upgrade
PB Ratio
33.9218.586.859.263.002.19
Upgrade
P/TBV Ratio
34.0118.636.879.283.012.20
Upgrade
EV/Sales Ratio
63.5284.83-4164.237.09-
Upgrade
Debt / Equity Ratio
1.081.120.210.050.040.03
Upgrade
Asset Turnover
0.290.11-0.000.21-
Upgrade
Quick Ratio
8.3010.2432.5312.464.9113.82
Upgrade
Current Ratio
8.8610.6333.3312.775.0914.26
Upgrade
Return on Equity (ROE)
-72.61%-76.42%-22.67%-36.30%-33.39%-57.25%
Upgrade
Return on Assets (ROA)
-20.64%-24.13%-14.64%-18.53%-18.45%-31.68%
Upgrade
Return on Capital (ROIC)
-22.55%-25.72%-15.34%-20.93%-20.92%-35.14%
Upgrade
Earnings Yield
-2.13%-4.56%-3.18%-3.22%-12.53%-16.07%
Upgrade
FCF Yield
-1.58%-3.23%-2.94%-2.81%-7.50%-11.14%
Upgrade
Buyback Yield / Dilution
-3.21%-2.86%-19.86%-11.81%-79.97%-149.64%
Upgrade
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q